Evidence map›Paper›PMID 26437974›Full record

ReviewDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2015

Immunomodulatory effect of hypertonic saline in hemorrhagic shock.

Javad Motaharinia, Farhad Etezadi, Azadeh Moghaddas, Mojtaba Mojtahedzadeh

Open access · hybridAbstract readReview
In one paragraph

Review in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Javad MotahariniaDepartment of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Ave, Enghelab Sq, Tehran, Iran. motahariniaj@gmail.com.
Farhad EtezadiDepartment of Anesthesiology & Critical Care, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. etezadi@sina.tums.ac.ir.
Azadeh MoghaddasDepartment of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Ave, Enghelab Sq, Tehran, Iran. zadeh-moghaddas@yahoo.com.
Mojtaba MojtahedzadehDepartment of Pharmacotherapy, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Ave, Enghelab Sq, Tehran, Iran. mojtahed@tums.ac.ir.
Tehran University of Medical Sciences · IRIran University of Medical Sciences · IRSina Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple organ dysfunction syndrome (MODS) and nosocomial infection following trauma-hemorrhage are among the most important causes of mortality in hemorrhagic shock patients. Dysregulation of the immune system plays a central role in MODS and a fluid having an immunomodulatory effect could be advantageous in hemorrhagic shock resuscitation. Hypertonic saline (HS) is widely used as a resuscitation fluid in trauma-hemorrhagic patients. Besides having beneficial effects on the hemodynamic parameters, HS has modulatory effects on various functions of immune cells such as degranulation, adhesion molecules and cytokines expression, as well as reactive oxygen species production. This article reviews clinical evidence for decreased organ failure and mortality in hemorrhagic shock patients resuscitated with HS. Despite promising results in animal models, results from pre-hospital and emergency department administration in human studies did not show improvement in survival, organ failure, or a reduction in nosocomial infection by HS resuscitation. Further post hoc analysis showed some benefit from HS resuscitation for severely-injured patients, those who received more than ten units of blood by transfusion, patients who underwent surgery, and victims of traumatic brain injury. Several reasons are suggested to explain the differences between clinical and animal models.

Indexed as

AnimalsCross InfectionHumansMultiple Organ FailureRandomized Controlled Trials as TopicRisk FactorsSaline Solution, HypertonicShock, HemorrhagicSurvival AnalysisTreatment OutcomeSaline Solution, Hypertonic

Identifiers

PMID26437974
PMCPMC4593217
OpenAlexW1934911472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.